SE8803248L - Anvaendning av inositoltrifosfat foer framstaellning av laekemedel - Google Patents

Anvaendning av inositoltrifosfat foer framstaellning av laekemedel

Info

Publication number
SE8803248L
SE8803248L SE8803248A SE8803248A SE8803248L SE 8803248 L SE8803248 L SE 8803248L SE 8803248 A SE8803248 A SE 8803248A SE 8803248 A SE8803248 A SE 8803248A SE 8803248 L SE8803248 L SE 8803248L
Authority
SE
Sweden
Prior art keywords
preparation
medicinal products
inositol triphosphate
inositol
triphosphate
Prior art date
Application number
SE8803248A
Other languages
Unknown language ( )
English (en)
Other versions
SE464059C (sv
SE464059B (sv
SE8803248D0 (sv
Inventor
M Siren
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE8803248A priority Critical patent/SE464059C/sv
Publication of SE8803248D0 publication Critical patent/SE8803248D0/sv
Priority to EP89117030A priority patent/EP0359258B1/en
Priority to GB8920804A priority patent/GB2223167B/en
Priority to AT8989117030T priority patent/ATE104855T1/de
Priority to JP1237429A priority patent/JP2859318B2/ja
Priority to ES89117032T priority patent/ES2054965T3/es
Priority to EP89117028A priority patent/EP0359256B1/en
Priority to DE68914922T priority patent/DE68914922T2/de
Priority to GB8920806A priority patent/GB2223169B/en
Priority to JP1237427A priority patent/JP2547257B2/ja
Priority to DE8989117031T priority patent/DE68902526T2/de
Priority to EP89117031A priority patent/EP0359259B1/en
Priority to GB8920805A priority patent/GB2223168B/en
Priority to AT89117029T priority patent/ATE120958T1/de
Priority to GB8920807A priority patent/GB2223403B/en
Priority to JP1237431A priority patent/JP3058334B2/ja
Priority to DE89117032T priority patent/DE68906106T2/de
Priority to ES89117029T priority patent/ES2073419T3/es
Priority to EP89117029A priority patent/EP0359257B1/en
Priority to JP1237430A priority patent/JP2859319B2/ja
Priority to AT89117031T priority patent/ATE79542T1/de
Priority to ES89117031T priority patent/ES2043998T3/es
Priority to JP1237428A priority patent/JPH02191218A/ja
Priority to EP89117032A priority patent/EP0359260B1/en
Priority to ES89117030T priority patent/ES2055772T3/es
Priority to AT89117032T priority patent/ATE88347T1/de
Priority to GB8920811A priority patent/GB2223404B/en
Priority to DE68922165T priority patent/DE68922165T2/de
Priority to ES89117028T priority patent/ES2045319T3/es
Priority to AT89117028T priority patent/ATE84719T1/de
Priority to DE8989117028T priority patent/DE68904507T2/de
Publication of SE8803248L publication Critical patent/SE8803248L/sv
Priority to SE9003395A priority patent/SE9003395L/sv
Publication of SE464059B publication Critical patent/SE464059B/sv
Priority to GR920400982T priority patent/GR3005448T3/el
Priority to GR920402459T priority patent/GR3006825T3/el
Priority to GR930400188T priority patent/GR3007686T3/el
Priority to GR940403975T priority patent/GR3015764T3/el
Publication of SE464059C publication Critical patent/SE464059C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8803248A 1988-09-15 1988-09-15 Användning av inositoltrifosfat för framställning av läkemedel SE464059C (sv)

Priority Applications (36)

Application Number Priority Date Filing Date Title
SE8803248A SE464059C (sv) 1988-09-15 1988-09-15 Användning av inositoltrifosfat för framställning av läkemedel
DE8989117028T DE68904507T2 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat bei der behandlung der beschaedigung von gewebe.
EP89117029A EP0359257B1 (en) 1988-09-15 1989-09-14 Use of inositol triphosphate in the preparation of a medicament against diabetes
AT89117028T ATE84719T1 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat bei der behandlung der beschaedigung von gewebe.
AT8989117030T ATE104855T1 (de) 1988-09-15 1989-09-14 Verwendung von inositoltrisphosphat zur herstellung eines arzneimittels gegen knochenerkrakungen.
JP1237429A JP2859318B2 (ja) 1988-09-15 1989-09-14 イノシトールトリホスフェートを含有する骨疾患に対する医薬
ES89117032T ES2054965T3 (es) 1988-09-15 1989-09-14 El uso de un isomero de trifosfato de inositol para la preparacion de un medicamento contra niveles anormales de lipoproteinas en mamiferos.
EP89117028A EP0359256B1 (en) 1988-09-15 1989-09-14 The use of inositoltrisphosphate in the treatment of tissue damage
DE68914922T DE68914922T2 (de) 1988-09-15 1989-09-14 Verwendung von Inositoltrisphosphat zur Herstellung eines Arzneimittels gegen Knochenerkrakungen.
GB8920806A GB2223169B (en) 1988-09-15 1989-09-14 Inositol trisphosphate for the treatment of bone disorders
JP1237430A JP2859319B2 (ja) 1988-09-15 1989-09-14 イノシトールトリホスフェートを含有する移植に関する障害に対する医薬
DE8989117031T DE68902526T2 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat zur herstellung eines arzneimittels gegen stoerungen bei transplantationen.
EP89117031A EP0359259B1 (en) 1988-09-15 1989-09-14 The use of inositoltrisphosphate for the preparing of a medicament against transplantation disorders
GB8920805A GB2223168B (en) 1988-09-15 1989-09-14 Pharmaceutical composition comprising inositoltrisphosphate for the treatment of complications of diabetes
AT89117029T ATE120958T1 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat zur herstellung eines arzneimittels gegen diabetes.
GB8920807A GB2223403B (en) 1988-09-15 1989-09-14 Inositoltrisphosphate for the treatment of disorders related to transplantation
JP1237431A JP3058334B2 (ja) 1988-09-15 1989-09-14 イノシトールトリホスフェートを含有するリポ蛋白質の異常レベルに対する医薬
DE89117032T DE68906106T2 (de) 1988-09-15 1989-09-14 Verwendung von Inositoltriphosphat zur Herstellung eines Arzneimittels gegen abnorme Konzentrationen von Lipoproteinen.
ES89117029T ES2073419T3 (es) 1988-09-15 1989-09-14 Uso de inositatrifosfato en la preparacion de un medicamento contra la diabetes.
EP89117030A EP0359258B1 (en) 1988-09-15 1989-09-14 The use of inositoltrisphosphate for the preparing of a medicament against bone disorders
JP1237427A JP2547257B2 (ja) 1988-09-15 1989-09-14 イノシトールトリホスフェートを含有する組織の損傷に対する医薬
AT89117031T ATE79542T1 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat zur herstellung eines arzneimittels gegen stoerungen bei transplantationen.
GB8920811A GB2223404B (en) 1988-09-15 1989-09-14 Inositoltrisphosphate for the treatment of abnormal levels of lipoproteins
JP1237428A JPH02191218A (ja) 1988-09-15 1989-09-14 イノシトールトリホスフェートを含有する糖尿病の合併症に対する医薬
EP89117032A EP0359260B1 (en) 1988-09-15 1989-09-14 The use of inositoltrisphosphate for the preparing of a medicament against abnormal levels of lipoproteins
ES89117030T ES2055772T3 (es) 1988-09-15 1989-09-14 Uso del inositoltrisfosfato para la preparacion de un medicamento frente a alteraciones oseas.
AT89117032T ATE88347T1 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat zur herstellung eines arzneimittels gegen abnorme konzentrationen von lipoproteinen.
ES89117031T ES2043998T3 (es) 1988-09-15 1989-09-14 El uso de inositoltrisfosfato para la preparacion de un medicamento contra los trastornos relacionados con trasplantes.
DE68922165T DE68922165T2 (de) 1988-09-15 1989-09-14 Verwendung von Inositoltriphosphat zur Herstellung eines Arzneimittels gegen Diabetes.
ES89117028T ES2045319T3 (es) 1988-09-15 1989-09-14 El uso del trifosfato de inosita en el tratamiento de da\os de tejido.
GB8920804A GB2223167B (en) 1988-09-15 1989-09-14 Inositoltrisphosphate for the treatment of tissue damage
SE9003395A SE9003395L (sv) 1988-09-15 1990-10-24 Anvaendning av inositoltrifosfat foer framstaellning av laekemedel
GR920400982T GR3005448T3 (sv) 1988-09-15 1992-08-20
GR920402459T GR3006825T3 (sv) 1988-09-15 1993-01-21
GR930400188T GR3007686T3 (sv) 1988-09-15 1993-04-22
GR940403975T GR3015764T3 (en) 1988-09-15 1995-04-13 Use of inositol triphosphate in the preparation of a medicament against diabetes.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803248A SE464059C (sv) 1988-09-15 1988-09-15 Användning av inositoltrifosfat för framställning av läkemedel

Publications (4)

Publication Number Publication Date
SE8803248D0 SE8803248D0 (sv) 1988-09-15
SE8803248L true SE8803248L (sv) 1990-03-16
SE464059B SE464059B (sv) 1991-03-04
SE464059C SE464059C (sv) 1996-12-04

Family

ID=20373330

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8803248A SE464059C (sv) 1988-09-15 1988-09-15 Användning av inositoltrifosfat för framställning av läkemedel
SE9003395A SE9003395L (sv) 1988-09-15 1990-10-24 Anvaendning av inositoltrifosfat foer framstaellning av laekemedel

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE9003395A SE9003395L (sv) 1988-09-15 1990-10-24 Anvaendning av inositoltrifosfat foer framstaellning av laekemedel

Country Status (8)

Country Link
EP (5) EP0359260B1 (sv)
JP (5) JP3058334B2 (sv)
AT (5) ATE79542T1 (sv)
DE (5) DE68904507T2 (sv)
ES (5) ES2045319T3 (sv)
GB (5) GB2223168B (sv)
GR (4) GR3005448T3 (sv)
SE (2) SE464059C (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330979A (en) * 1984-10-23 1994-07-19 Perstorp Ab Method of treating renal disorders with inositoltriphosphate
US5427956A (en) * 1989-03-08 1995-06-27 The University Of Virginia Patent Foundation Quantitative analysis for diabetic condition predictor
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
ES2146197T3 (es) * 1989-03-08 2000-08-01 Univ Virginia Suplemento dietetico para diabeticos resistentes a la insulina.
SE9002278L (sv) * 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
SE467340B (sv) * 1990-07-04 1992-07-06 Perstorp Ab Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist
JP2750239B2 (ja) * 1991-08-14 1998-05-13 三共株式会社 アデノホスチンａまたはｂならびにその製法
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
SE9600194D0 (sv) * 1996-01-19 1996-01-19 Perstorp Ab A new chemical compound
SE9601396D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 2
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
SE9602463D0 (sv) * 1996-06-24 1996-06-24 Perstorp Ab The use of growth factor modulating compounds
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
US5906979A (en) * 1998-01-27 1999-05-25 Insmed Pharmaceuticals, Inc. Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
US6486127B1 (en) 2001-05-23 2002-11-26 Insmed, Incorporated Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof
KR100653557B1 (ko) * 2001-10-06 2006-12-05 아미코젠주식회사 카이로 이노시톨 또는 피니톨의 백내장 예방치료제로서의용도와 그 조성물
CN111246852A (zh) * 2017-10-26 2020-06-05 大塚制药株式会社 含有磷酸肌醇的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel

Also Published As

Publication number Publication date
GB2223168B (en) 1992-08-12
JP3058334B2 (ja) 2000-07-04
DE68922165D1 (de) 1995-05-18
ATE84719T1 (de) 1993-02-15
GB8920805D0 (en) 1989-11-01
GB8920807D0 (en) 1989-11-01
EP0359258A3 (en) 1990-10-03
GR3015764T3 (en) 1995-07-31
EP0359256A2 (en) 1990-03-21
DE68904507T2 (de) 1993-06-09
ES2054965T3 (es) 1994-08-16
DE68922165T2 (de) 1995-09-14
GB2223404B (en) 1992-04-08
GB2223403B (en) 1992-02-26
EP0359257A2 (en) 1990-03-21
GB2223169A (en) 1990-04-04
EP0359256A3 (en) 1990-10-10
EP0359256B1 (en) 1993-01-20
GR3007686T3 (sv) 1993-08-31
GB2223404A (en) 1990-04-11
DE68904507D1 (de) 1993-03-04
ATE104855T1 (de) 1994-05-15
SE464059C (sv) 1996-12-04
JPH02191218A (ja) 1990-07-27
GB8920811D0 (en) 1989-11-01
EP0359259A3 (en) 1990-10-03
ES2045319T3 (es) 1994-01-16
EP0359260A3 (en) 1990-10-03
JPH02191220A (ja) 1990-07-27
JP2859318B2 (ja) 1999-02-17
SE464059B (sv) 1991-03-04
GB8920804D0 (en) 1989-11-01
EP0359258A2 (en) 1990-03-21
EP0359257A3 (en) 1990-10-03
DE68914922D1 (de) 1994-06-01
ATE88347T1 (de) 1993-05-15
EP0359259A2 (en) 1990-03-21
GR3006825T3 (sv) 1993-06-30
ATE120958T1 (de) 1995-04-15
JPH02191219A (ja) 1990-07-27
EP0359257B1 (en) 1995-04-12
ES2055772T3 (es) 1994-09-01
DE68906106D1 (de) 1993-05-27
JPH02191217A (ja) 1990-07-27
GB2223167B (en) 1992-02-26
EP0359258B1 (en) 1994-04-27
EP0359259B1 (en) 1992-08-19
DE68902526D1 (de) 1992-09-24
JP2547257B2 (ja) 1996-10-23
DE68914922T2 (de) 1994-09-01
DE68902526T2 (de) 1993-03-11
ES2043998T3 (es) 1994-01-01
SE8803248D0 (sv) 1988-09-15
GB2223403A (en) 1990-04-11
SE9003395L (sv) 1992-04-25
JP2859319B2 (ja) 1999-02-17
EP0359260A2 (en) 1990-03-21
SE9003395D0 (sv) 1990-10-24
ES2073419T3 (es) 1995-08-16
DE68906106T2 (de) 1993-10-21
GB2223167A (en) 1990-04-04
GR3005448T3 (sv) 1993-05-24
JPH02191221A (ja) 1990-07-27
ATE79542T1 (de) 1992-09-15
GB2223168A (en) 1990-04-04
EP0359260B1 (en) 1993-04-21
GB2223169B (en) 1992-04-08
GB8920806D0 (en) 1989-11-01

Similar Documents

Publication Publication Date Title
SE9003395D0 (sv) Anvaendning av inositoltrifosfat foer framstaellning av laekemedel
ES2024010B3 (es) Unidad de dosis farmaceutica.
ES1006927Y (es) Zapato para pacientes que han sufrido operacion quirurgica en la parte delantera del pie.
ATE75613T1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8803248-7

Format of ref document f/p: F